Evelo Biosciences Stock Price Prediction
| EVLO Stock | USD 0.0002 0.0003 60.00% |
Momentum 68
Buy Stretched
Oversold | Overbought |
Using Evelo Biosciences hype-based prediction, you can estimate the value of Evelo Biosciences from the perspective of Evelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evelo Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Evelo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evelo Biosciences after-hype prediction price | USD 1.58E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evelo |
Evelo Biosciences After-Hype Price Density Analysis
As far as predicting the price of Evelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Evelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Evelo Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evelo Biosciences' historical news coverage. Evelo Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Evelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evelo Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Evelo Biosciences is based on 3 months time horizon.
Evelo Biosciences Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.79 | 52.77 | 0.00 | 0.00 | 8 Events / Month | 3 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0002 | 0.0002 | 20.88 |
|
Evelo Biosciences Hype Timeline
Evelo Biosciences is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Evelo is expected to decline in value after the next headline, with the price expected to drop to 1.58E-4. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -20.88%, whereas the daily expected return is currently at 3.79%. The volatility of related hype on Evelo Biosciences is about 1.0554E7%, with the expected price after the next announcement by competition of 0.00. About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 15.64. Evelo Biosciences had not issued any dividends in recent years. The entity had 1:20 split on the 30th of June 2023. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out Evelo Biosciences Basic Forecasting Models to cross-verify your projections.Evelo Biosciences Related Hype Analysis
Having access to credible news sources related to Evelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Evelo Biosciences' future price movements. Getting to know how Evelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INFIQ | Infinity Pharmaceuticals | 0.00 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIFS | Life Stem Genetics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARDS | Aridis Pharmaceuticals | 0.00 | 0 per month | 37.27 | 0.33 | 1,000.00 | (90.48) | 1,141 | |
| STAB | Statera Biopharma | 0.00 | 0 per month | 21.36 | 0.16 | 100.00 | (66.67) | 275.00 | |
| TRVN | Trevena | 0.00 | 6 per month | 0.00 | 0.11 | 0.00 | 0.00 | 1,000.00 | |
| ICCT | iCoreConnect Common stock | 0.01 | 16 per month | 29.14 | 0.18 | 100.00 | (66.67) | 522.73 | |
| HSTC | HST Global | 0.00 | 0 per month | 0.00 | 0.18 | 0.00 | 0.00 | 4,954 | |
| PXMD | PaxMedica Common Stock | 0.00 | 14 per month | 0.00 | 0.12 | 0.00 | 0.00 | 4,998 | |
| BTAX | Biostax Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SECI | Sector 10 | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Evelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Evelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evelo using various technical indicators. When you analyze Evelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evelo Biosciences Predictive Indicators
The successful prediction of Evelo Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evelo Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evelo Biosciences based on analysis of Evelo Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evelo Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evelo Biosciences's related companies.
Pair Trading with Evelo Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Evelo Pink Sheet
| 0.52 | VWAGY | Volkswagen AG 110 | PairCorr |
| 0.48 | VLKAF | Volkswagen AG | PairCorr |
| 0.43 | VLKPF | Volkswagen AG VZO | PairCorr |
| 0.41 | CSCO | Cisco Systems | PairCorr |
| 0.37 | VZ | Verizon Communications Earnings Call This Week | PairCorr |
| 0.36 | WMT | Walmart Common Stock Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Evelo Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evelo Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evelo Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evelo Biosciences to buy it.
The correlation of Evelo Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evelo Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evelo Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evelo Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Evelo Pink Sheet
Evelo Biosciences financial ratios help investors to determine whether Evelo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evelo with respect to the benefits of owning Evelo Biosciences security.